Chimeric Antigen Receptor (CAR) T cells hold significant therapeutic potential, but their manufacturing workflow is both complex and tightly regulated, requiring thorough in vitro characterization before patient infusion. Simple Plex™ assays, run on the Ella™ automated ELISA platform, offer a precise and rapid solution for assessing T cell activation markers.
Learn how these assays support cell therapy development and manufacturing efficiency by delivering accurate, reproducible results for key markers such as Granzyme B, IFN-γ, IL-2, and TNF-α in just 90 minutes, streamlining CAR T cell workflows and advancing cell therapy characterization.
